Pfizer Czech Republic - Pre-Tax Profit Growth

Pfizer CR`s Pre-Tax Profit Growth reached 34.4 % in 2017. This is 1670 % more than in the previous year.

$1.99

Buy Pre-Tax Profit Growth data for Pfizer Czech Republic.

$19.99

Buy all data for Pfizer Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ...           55.9 -37.5 9.53 30.0 -12.4    
Bayer Czech Republic ... ... ...               27.9 -47.7 20.5 10.1 19.8    
GlaxoSmithKline Czech Republic ... ... ...               32.4 -25.9 -23.1 -28.4 33.3    
Merck Czech Republic ... ...                 208 20.3 -41.4 9.51 89.2    
Novartis Czech Republic                     -1.98 -2.34 4.60 70.8 17.6    
Pfizer Czech Republic ... ...                 132 -79.1 198 -6.94 -44.5    
Roche Czech Republic ... ... ...               -39.1 -14.2 157 -26.8 -39.4   ...
Sanofi-Aventis Czech Republic ... ... ... ...             51.8 -18.2 50.6 -98.0 5,393    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... 6.02 1.33 12.5    
Walmark ... ... ...               44.2 -91.9 -108 -4,319 -1,273